(RTTNews) - CorVel Corp. (CRVL) released earnings for its fourth quarter that Increased, from the same period last year The company's bottom line totaled $31.029 million, or $0.61 per share. This compares with $26.419 million, or $0.51 per share, last year. The company's revenue for the period rose 7.4% to $248.548 million from $231.514 million last year. CorVel Corp. earnings at a glance (GAAP) :...
(RTTNews) - CorVel Corp. (CRVL) released earnings for its fourth quarter that Increased, from the same period last year The company's bottom line totaled $31.029 million, or $0.61 per share. This compares with $26.419 million, or $0.51 per share, last year. The company's revenue for the period rose 7.4% to $248.548 million from $231.514 million last year. CorVel Corp. earnings at a glance (GAAP) : -Earnings: $31.029 Mln. vs. $26.419 Mln. last year. -EPS: $0.61 vs. $0.51 last year. -Revenue: $248.548 Mln vs. $231.514 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - Samsung Electronics Co. Ltd.'s (SSNLF) more than 47,000 workers are likely to begin an 18-day strike on Thursday following the failure of wage negotiations between the company and its labor union. The South Korean government-mediated wage negotiations' core issue remained bonus disputes between the company and the union. The talks involve union's demands over performance-based bonuses ...
(RTTNews) - Samsung Electronics Co. Ltd.'s (SSNLF) more than 47,000 workers are likely to begin an 18-day strike on Thursday following the failure of wage negotiations between the company and its labor union. The South Korean government-mediated wage negotiations' core issue remained bonus disputes between the company and the union. The talks involve union's demands over performance-based bonuses and the company's pay structure, as well as the removal of bonus payout caps and greater transparency. As per reports, the union had agreed to the mediation proposal from South Korea's National Labor Relations Commission, but Samsung rejected it, and asked for more time for negotiations. Meanwhile, Samsung Electronics stated that no decision has been made. According to the firm, accepting the labor union's excessive demands could undermine the fundamental principles of company management. Choi Seung-ho, the spokesperson for the labor union reportedly said, "We express deep regret that the post-mediation process was terminated due to the delay in management's decision-making.' It is expected that that the disrupt in Samsung's memory and AI chip production following the days-long strike would have a massive impact on the company's operating profit and shipments. Amid the developments, there is a speculation of government-forced arbitration as South Korean Finance Minister Koo Yun-cheol and President Lee Jae-Myung reportedly stated that a strike would pose a major risk to national economic growth and exports. In South Korea, Samsung shares closed Wednesday's trading at 276,000.00 won, up 0.18 percent. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
FREDERICA ABAN/iStock via Getty Images Market overview The first quarter of 2026 saw relatively stable performance across most asset classes in January and February but was ultimately defined by the outbreak of war in Iran in March. The S&P 500 Index fell 4.33%, marking its worst quarterly performance since the third quarter of 2022. The Russell 3000 Index, another measure of U.S. equities, fell 3...
FREDERICA ABAN/iStock via Getty Images Market overview The first quarter of 2026 saw relatively stable performance across most asset classes in January and February but was ultimately defined by the outbreak of war in Iran in March. The S&P 500 Index fell 4.33%, marking its worst quarterly performance since the third quarter of 2022. The Russell 3000 Index, another measure of U.S. equities, fell 3.96%. Within the U.S. equity market, large-cap growth stocks were hit particularly hard, with the Russell 1000 Growth Index declining 9.78% as compared to a 2.10% gain for the Russell 1000 Value Index. Indeed, growth-oriented stocks across the capitalization spectrum lagged value-oriented stocks. Mid-cap and small-cap stocks overall outperformed large-cap stocks, as measured by the 1.29% and 0.89% gains of the Russell Midcap Index and Russell 2000 Index, respectively, as compared to the -4.18% return of the Russell 1000 Index. Internationally, the MSCI EAFE Index, measuring developed market equities, fell 1.24%, and the MSCI Emerging Markets Index, measuring emerging markets equities, returned -0.17%, each in U.S. dollar terms, as U.S. dollar appreciation weighed on dollar-based returns from overseas markets, offsetting otherwise healthy equity performance abroad. Fixed-income market returns were muted across the quality spectrum, as inflation expectations shifted upward with the U.S.-Iran war. The U.S. Federal Reserve held interest rates steady, and the outlook for cuts was called into question. The Bloomberg U.S. Aggregate Bond Index returned -0.05%. U.S. Treasuries, per the Bloomberg Treasury Index, returned -0.04%, Investment-grade corporate bonds, per the Bloomberg U.S. Corporate Bond Index, returned -0.54%, and high-yield corporate bonds, per the Bloomberg U.S. Corporate High Yield Index, returned -0.50%. Securitized assets, per the Bloomberg U.S. Securitized Index, rose 0.40%. Emerging markets debt returned -1.35%, as measured by the Bloomberg Emerging Markets USD Ag...
China scaled back government spending at its fastest pace in six months in April, a move that contributed to an unexpected slowdown in the economy across the board. A broad measure of public expenditure fell 7.3% from a year ago, accelerating from the 2.5% decrease in March to mark its sharpest decline since October, according to Bloomberg calculations based on Ministry of Finance data released We...
China scaled back government spending at its fastest pace in six months in April, a move that contributed to an unexpected slowdown in the economy across the board. A broad measure of public expenditure fell 7.3% from a year ago, accelerating from the 2.5% decrease in March to mark its sharpest decline since October, according to Bloomberg calculations based on Ministry of Finance data released Wednesday. By contrast, broad fiscal revenue rose 2%. The data helps explain a surprising contraction in fixed-asset investment that China recorded in April, which followed a rebound earlier this year. Combined with sluggish consumer spending, the investment downturn outweighed booming exports, dragging down overall economic activity. Economists have pointed to several reasons for the fiscal pullback. Solid economic growth in the first quarter may have reduced the impetus for authorities to step up spending. Others noted a potential funding gap in April, as some construction projects were moved from late 2025 to early 2026 while new projects had yet to receive approval. Officials may also have faced pressure to repay arrears to companies. Infrastructure-related expenditure under China’s main budget plunged 17.7% in April from a year earlier, worsening from the 8.5% drop in March, according to Bloomberg calculations. China will likely increase infrastructure spending to shore up growth. Some economists estimate that China’s economic expansion slowed to roughly 4% in April, tracking below the government’s official full-year target of 4.5% to 5%. In April, the Communist Party’s decision-making Politburo pledged to accelerate the construction of infrastructure networks spanning water, electricity, computing power, telecommunications, urban underground pipes and logistics. Investment in those projects could exceed 7 trillion yuan ($1 trillion) this year, according to Sinolink Securities’ estimate .
Belite Bio press release ( BLTE ): Q1 Non-GAAP EPS of -$0.34 beats by $0.30 . Cash and Cash Equivalents: As of March 31, 2026, the Company had $276.4 million in cash and cash equivalents, compared with $352.9 million on December 31, 2025. Investments: As of March 31, 2026, the Company had $522.2 million in U.S. treasury bills and U.S. treasury notes, compared to $419.7 million as of December 31, 2...
Belite Bio press release ( BLTE ): Q1 Non-GAAP EPS of -$0.34 beats by $0.30 . Cash and Cash Equivalents: As of March 31, 2026, the Company had $276.4 million in cash and cash equivalents, compared with $352.9 million on December 31, 2025. Investments: As of March 31, 2026, the Company had $522.2 million in U.S. treasury bills and U.S. treasury notes, compared to $419.7 million as of December 31, 2025. More on Belite Bio Belite Bio, Inc (BLTE) Presents at Bank of America Global Healthcare Conference 2026 Transcript Belite Bio, Inc (BLTE) Presents at FFB Retinal Therapeutics Innovation Summit - Slideshow Belite Bio, Inc (BLTE) Presents at Deutsche Bank ADR Virtual Investor Conference - Slideshow Belite Bio targets Q2 2026 NDA submission and $200M–$250M commercialization spend for Stargardt therapy while cash reserves surge Seeking Alpha’s Quant Rating on Belite Bio
(RTTNews) - Target Corp (TGT) will host a conference call at 8:00 AM ET on May 20, 2026, to discuss Q1 26 earnings results. To access the live webcast, log on to https://corporate.target.com/investors/events-presentations The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
(RTTNews) - Target Corp (TGT) will host a conference call at 8:00 AM ET on May 20, 2026, to discuss Q1 26 earnings results. To access the live webcast, log on to https://corporate.target.com/investors/events-presentations The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The Roundhill Memory ETF (CBOE:DRAM) is the kind of fund that arrives with a thesis already pricing in. Launched on April 2, 2026, DRAM has run from $28 at inception to $49, a 77% gain in roughly six weeks, before giving back 10% in the past week alone. For investors who came to DRAM as ... The Memory Pricing Cycle That Could Crush This AI ETF Before Year-End
The Roundhill Memory ETF (CBOE:DRAM) is the kind of fund that arrives with a thesis already pricing in. Launched on April 2, 2026, DRAM has run from $28 at inception to $49, a 77% gain in roughly six weeks, before giving back 10% in the past week alone. For investors who came to DRAM as ... The Memory Pricing Cycle That Could Crush This AI ETF Before Year-End
FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $959 million, a 7% increase from $896 million during the fiscal year ended March 31, 2025. Earnings per share for the fiscal year ended March 31, 2026 were $2.14, up 17% compared to $...
FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $959 million, a 7% increase from $896 million during the fiscal year ended March 31, 2025. Earnings per share for the fiscal year ended March 31, 2026 were $2.14, up 17% compared to $1.83 during the fiscal year ended March 31, 2025. Revenues for the quarter were $249 million, an increase from $232 million in the March quarter of 2025. Earnings per share for the quarter were $0.61, up 20% compared to $0.51 in the same quarter of the prior year. Fourth Quarter Fiscal Year 2026 Highlights Revenue increased 7% to $249 million, compared to fourth quarter of fiscal year 2025. Gross profit increased 9% to $63.0 million, at 25% gross margin, compared to fourth quarter of fiscal year 2025 gross profit of $58.0 million. Exited the quarter with $233 million of cash, cash equivalents, and no borrowings. The Company repurchased $20.1 million of common stock during the quarter. CERIS, CorVel’s health division, is benefiting from the healthcare industry’s shift toward proactive payment accuracy and cost management, with strong demand for its integrated prepay and post-pay platform that improves claims accuracy, reduces administrative burden, and enhances revenue visibility. During the quarter, multiple large payer sales with enterprise-scale implementations reflect the strength of the value proposition and provide increased revenue visibility as they are deployed and scaled over time. As adoption of prepay solutions expands, CERIS is accelerating revenue realization cycles while maintaining strong margin profiles, supported by ongoing investment in AI and automation. Within workers’ compensation and risk management, P&C services are advancing its technology-enabled, clinically integrated model through the CorVel ConnectedTM interface within its proprietary CareMC plat...
Micron shares rise on the prospect of a strike affecting rival memory-chip maker Samsung, while Nvidia climbs ahead of its earnings report due after the closing bell Wednesday.
Micron shares rise on the prospect of a strike affecting rival memory-chip maker Samsung, while Nvidia climbs ahead of its earnings report due after the closing bell Wednesday.